Sorafenib Neoadjuvant Therapy in the Treatment of High Risk Renal Cell Carcinoma

OBJECTIVE: To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC). MATERIALS AND METHODS: Clinical data of 18 patients with high risk RCC who received surgery done successfully after preoperative neoadjuvant therapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yushi, Li, Yongqiang, Deng, Jianhua, Ji, Zhigang, Yu, Hongyan, Li, Hanzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315594/
https://www.ncbi.nlm.nih.gov/pubmed/25647522
http://dx.doi.org/10.1371/journal.pone.0115896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315594/
https://www.ncbi.nlm.nih.gov/pubmed/25647522
http://dx.doi.org/10.1371/journal.pone.0115896

Ejemplares similares